País: República de Sud-àfrica
Idioma: anglès
Font: South African Health Products Regulatory Authority (SAHPRA)
Lennon
LENAZINE® FORTE COUGH LINCTUS SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form): LENAZINE ® FORTE COUGH LINCTUS COMPOSITION: Each 5 mL contains: Codeine Phosphate 9,0 mg Ephedrine Hydrochloride 7,2 mg Promethazine Hydrochloride 3,6 mg In a flavoured syrup base Preservative: Methyl hydroxybenzoate 0,1 % m/v PHARMACOLOGICAL CLASSIFICATION: A 10.1 Antitussives and expectorants INDICATIONS: For the alleviation of cough. CONTRA-INDICATIONS: Contra-indicated in respiratory depression, acute alcoholism, head injuries and conditions in which intracranial pressure is raised. Lenazine Forte Cough Linctus should not be given to patients receiving mono-amine oxidase inhibitors or within 14 days of its termination. It should also not be given to premature infants or neonates. It is contra-indicated during acute attacks of asthma and in heart failure secondary to chronic lung disease Safety in pregnancy has not been established WARNING: This medicine may lead to drowsiness and impaired concentration, which may be aggravated by the simultaneous intake of alcohol, or any other central nervous system depressant agents. Patients should be warned not to drive a motor vehicle, operate dangerous machinery or climb dangerous heights, as impaired decision making could lead to accidents. DOSAGE AND DIRECTIONS FOR USE: Adults - One to two (5 mL) medicine measures 2 to 3 times a day. Children - 12 years: One to one and a half (5 mL) medicine measures 2 to 3 times a day. 7 years: Half to one (5 mL) medicine measure 2 to 3 times a day. 1 year: Quarter to half a (5 mL) medicine measure 2 to 3 times a day. SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Codeine Phosphate: The most common side-effects are nausea, vomiting, constipation, drowsiness and confusion. Difficulty in micturition, Llegiu el document complet